Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine.
about
De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy.Ginseng extracts restore high-glucose induced vascular dysfunctions by altering triglyceride metabolism and downregulation of atherosclerosis-related genes.Outside the operating room: unlimited directions in research and beyondActivation of hexosamine pathway impairs nitric oxide (NO)-dependent arteriolar dilations by increased protein O-GlcNAcylation.Perturbations of the stress-induced GLUT4 localization pathway in slow-twitch muscles of obese Zucker rats.The chlorite-based drug WF10 constantly reduces hemoglobin A1c values and improves glucose control in diabetes patients with severe foot syndrome.In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.
P2860
Q33419872-1BBCBEAC-4544-43F4-9732-CE8B3DA2DE12Q36861641-0F938307-6D39-47C7-B4E0-7AD607CA3EB4Q37249857-267F7FA8-C3FE-4DF5-B34B-9DBEF30CFD85Q41760263-3E28BCAB-731F-4C6E-9E2C-B227B9806BC5Q42160397-5B5CA81E-55AE-47EE-8682-7827C46B3FDDQ42484411-A25CB8F2-31DC-490E-9E69-CAF52FC9846EQ46715312-273A0467-4235-44CE-AA5B-16F5285FCC53Q46724329-4D04C518-2921-4BAA-947C-724EA44384C2
P2860
Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@ast
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@en
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@nl
type
label
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@ast
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@en
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@nl
prefLabel
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@ast
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@en
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@nl
P2860
P356
P1476
Obesity, glucose intolerance a ...... tions for laboratory medicine.
@en
P2093
Marek H Dominiczak
P2860
P304
P356
10.1515/CCLM.2003.194
P577
2003-09-01T00:00:00Z